logo
logo

Mikra Cellular Sciences Receives $8.5 Million In Funding To Launch Novel Therapeutic Product

Mar 09, 2022•over 3 years ago

Amount Raised

$8.5 Million

Toronto

Description

Mikra Cellular Sciences Inc. ("Mikra"), a biosciences company driving breakthrough applications of bioactive compounds to positively impact human health and intervene before pharmaceuticals are necessary, today announced $8.5 million in funding from its parent company, Lifeist Wellness Inc. The funding will be used in part to market and meet Mikra's consumer demand for its first product, CELLFTM (pronounced "self"), engineered to increase cellular performance and improve one's "healthspan," as well as fuel Mikra's continuous product development. CELLF currently has a waitlist of 40,000+ consumers, all of whom will gain access to the product via pre-sale today.

Company Information

Company

Mikra Cellular Sciences

Location

Toronto, Ontario, Canada

About

Mikra is a biological sciences and consumer wellness company on a mission to increase your healthspan by focusing on the tiniest aspect of your health: the cell. People are made up of over 37 trillion cells with a variety of different sizes, shapes, functions and lifespan. These cells are responsible for energy, happiness, recovery potential and so much more. Mikra is exploring the link between changes at a cellular level and the cascading effects it can have on health. SOURCE Mikra